Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.

    Recruiting

    3 1
    Belgium France Germany Ireland Italy Poland +2
  • A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

    Recruiting

    3 1 1
    Investigated Diseases:
    Poland
  • A study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

    Recruiting

    3 1
    Romania
  • A study to evaluate the safety and how pivekimab sunirine works in children with relapsed or refractory acute myeloid leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Hungary Italy Spain
  • Optimizing fludarabine phosphate exposure to improve event‑free survival in children and young adults with B‑cell acute lymphoblastic leukemia receiving CAR‑T therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Germany The Netherlands Spain
  • A Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Poland +1
  • Long‑Term Safety and Efficacy of Infigratinib in Children with Hypochondroplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    Norway Spain
  • An observational study on the use of methotrexate in children and adolescents with Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • A study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France The Netherlands